Human papillomavirus type 6 L1 capsid protein antigen Active Not Recruiting Phase 4 Trials for Cervical Carcinoma / Human Papillomavirus (HPV) Infections Prevention

Indications	Status	Purpose	Phase
DBCOND0029674 (Cervical Carcinoma) DBCOND0147773 (Human Papillomavirus (HPV) Infections)	Active Not Recruiting	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT05237947	Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis fimbriae 2/3 antigen (DB10790) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992) Bordetella pertussis toxoid antigen (formaldehyde inactivated) (DB14388) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (DB10787) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Human papillomavirus type 11 L1 capsid protein antigen (DB10300) Human papillomavirus type 16 L1 capsid protein antigen (DB10301) Human papillomavirus type 18 L1 capsid protein antigen (DB10302) Human papillomavirus type 31 L1 capsid protein antigen (DB10310) Human papillomavirus type 33 L1 capsid protein antigen (DB10311) Human papillomavirus type 45 L1 capsid protein antigen (DB10312) Human papillomavirus type 52 L1 capsid protein antigen (DB10313) Human papillomavirus type 58 L1 capsid protein antigen (DB10314) Human papillomavirus type 6 L1 capsid protein antigen (DB10299) Pertussis vaccine (DB15274)